Leonardo Vinicius Barbosa

Dr. Leonardo Vinicius Barbosa

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2022 in Journal of Child Neurology
Verified
Journal Article
Closed access
ECEduardo Morais de Castro
Eduardo Morais de Castro
LBLeonardo Vinicius Barbosa
Leonardo Vinicius Barbosa
AFAline Simoneti Fonseca
Aline Simoneti Fonseca
SNSeigo Nagashima
Seigo Nagashima
CPCaroline Busatta Vaz de Paula
Caroline Busatta Vaz de Paula
Cleber Machado-SouzaCleber Machado-Souza
Cleber Machado-Souza
Background: Embryonic stem cell markers, such as SOX2, NANOG, and OCT4, are transcription factors expressed in pluripotent stem cells, involved in the mediation of pluripotency and self-renewal. Especially after the discovery of cancer stem cells, these proteins have been associated with several types of neoplasia, including astrocytomas. In the pediatric population, astrocytomas are the most common solid neoplasia and present the highest mortality rates. Methods: Our study evaluated 5 polymorphisms in SOX2, NANOG, and POU5F1 genes in 101 pediatric astrocytoma samples. Results: We describe the associations between wild and polymorphic alleles in astrocytomas. Conclusions: In our results, the intronic polymorphic G allele in SOX2 rs77677339 [G/A] had a borderline association with low-grade astrocytomas, and the intronic polymorphic T allele in NANOG rs10845877 [C/T] showed a higher frequency in grade 2, compared to grade 1 astrocytomas, thus showing promising results. Impact: Our study is relevant because it shows a potential correlation between polymorphic embryonic stem cell marker genes and pediatric astrocytomas.

22 July 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
JLJessica Zablocki da Luz
Jessica Zablocki da Luz
LBLeonardo Vinicius Barbosa
Leonardo Vinicius Barbosa
TSThiago Rodrigues dos Santos
Thiago Rodrigues dos Santos
Aliciane Almeida de Almeida RoqueAliciane Almeida de Almeida Roque
Aliciane Almeida de Almeida Roque
CCCamila Confortin
Camila Confortin
Cleber Machado-SouzaCleber Machado-Souza
Cleber Machado-Souza
Background/Objectives: Rhabdomyosarcoma (RMS), the most common pediatric soft tissue sarcoma, includes two main subtypes, embryonal (eRMS) and alveolar (aRMS), each with distinct molecular and clinical characteristics. Although cellular processes underlying RMS and differences between PAX3-FOXO1 fusion-positive and fusion-negative tumors are well known, the contribution of long noncoding RNAs (lncRNAs) remains poorly understood. Methods: Here, we reannotated publicly available microarray datasets to comprehensively profile lncRNA expression and reconstruct lncRNA–miRNA–mRNA regulatory networks in RMS. Results: We identified several lncRNAs with subtype-specific differential expression, including HOTAIR as a potential sponge for miR-206, DSCR8 for miR-885-5p, and PRKCQ-AS1 for miR-515-5p in eRMS. Database-supported interaction analyses identified putative regulatory relationships between these lncRNAs and cancer-related miRNAs and mRNAs. Validation using the St. Jude Cloud PeCan platform confirmed distinct lncRNA expression signatures across RMS subtypes and other pediatric solid tumors, supporting subtype-specific regulation. Conclusions: Our findings provide an updated characterization of the lncRNA landscape in RMS and identify candidate lncRNA–miRNA–mRNA regulatory networks that may contribute to disease biology. The proposed regulatory interactions are hypothesis-generating and require experimental validation. Overall, our findings provide a resource for future functional studies and support the investigation of lncRNAs as potential biomarkers and therapeutic targets in RMS.

12 November 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
LBLeonardo Vinicius Barbosa
Leonardo Vinicius Barbosa
AAAna Clara de Almeida
Ana Clara de Almeida
CTCui Tu
Cui Tu
RRRafael Roesler
Rafael Roesler
CFCaroline Brunetto de Farias
Caroline Brunetto de Farias
Cleber Machado-SouzaCleber Machado-Souza
Cleber Machado-Souza
Background/Objectives: Ewing sarcoma (ES) is an aggressive malignant cancer with a higher incidence in adolescents and young adults. Despite multimodal therapy, prognosis remains poor, particularly in metastatic and recurrence cases. Dysregulation of apoptosis is central to ES tumorigenesis; however, the impact of polymorphisms in apoptotic regulators on clinical outcomes remains unclear. This study investigated the association between single-nucleotide polymorphisms (SNPs) in the apoptotic pathway genes XAF1 and XIAP and their respective protein expression in ES outcomes. Methods: A cross-sectional study was conducted on ES samples from paraffin blocks (n = 55). Genotyping for selected SNPs and immunohistochemistry for XAF1 and XIAP expression were performed. The cohort included 41 pediatric and 14 non-pediatric cases. Statistical associations were analyzed between genotypes, age groups, protein expression, and recurrence. Results: The male sex (61.8%) and bone site (75.5%) were prevalent, while recurrence (30.9%) and metastasis (14.5%) were frequent outcomes. There was low or absent XAF1 expression (<1.2 μm2) in 75.5% of all ES cases, and 54.9% showed higher XIAP expression (≥16.4 μm2). The A allele present in the dominant group (AA + AG) of the rs3785793 [A/G] XAF1 gene, showed significantly lower XAF1 expression (p = 0.043) and was associated with recurrence in comparison to the GG genotype in pediatric ES. Conclusions: ES showed low or absent protein XAF1 expression and high XIAP expression. The wild-type A-allele of XAF1 rs3785793 was associated with decreased protein expression and increased recurrence outcome in pediatric ES. These findings suggest XAF1 polymorphism might be a potential biomarker for outcomes in ES, warranting further validation in larger prospective cohorts.